HUMAN MIXTARD

Presented By - PRASHANTH RAO

HUMAN MIXTARD

Brand Of NOVO NORDISK Denmark based company.

Indication in case of Diabetes Mellitus. Human Mixtard contains Premixed

Human Insulin.(30:70 & 50:50) 30% Regular Insulin & 70% NPH Insulin. 50% Regular Insulin & 50% NPH Insulin Its available as Human Mixtard 30 and

Human Mixtard 50.

NOVO NORDISK Market Leader in the Diabetic Segment. Only Company having all the range of

Insulin. REGULAR INSULIN (ACTRAPID) NPH INSULIN (INSULATARD) PREMIXED INSULIN (HUMAN MIXTARD

30 & 50) LONG ACTING DETIMIR INSULIN

(LEVIMIR) RAPID ACTING ASPART INSULIN

(NOVORAPID) PREMIXED ASPART INSULIN (NOVOMIX)

DEVICES AVAILABLEAvailable in the form of Vials,

Pens.

The Pens are also of 2 types, Prefilled Pens (Novolet) and Durable Pens (Novo Pen 3 and 4).

Vials are available in 40IU (10ml), where as the Pen fills are available in 100IU (3ml).

HUMAN MIXTARD VIALS 40IU10ml

HUMAN MIXTARD DURABLE PEN

NOVOPEN 4

HUMAN MIXTARD PEN FILLS

HUMAN MIXTARD PREFILLED PENS 10IU 3ml

PRICE HUMAN MIXTARD 30 VIAL-Rs.158

HUMAN MIXTARD PEN FILLS-Rs.1040 (Pack of 5)

NOVO PEN 3 –Rs.600

NOVOLET PEN (PREFILLED PEN)-Rs.300

COLLABORATIONS Torrent Manufactures Human Mixtard Vials at

their Ahmadabad unit (Same Quality).

Abott handles the Distribution of all the Insulins of Novo Nordisk.

The Pens and the Pen fills are Manufactured in Denmark and are Imported to India.

COMPETITORS

HUMINSULIN (ELI LILLY)WOSULIN (WOCKHARDT)LUPISULIN (LUPIN)INSUGEN (BIOCON)RECOSULIN (SHREYA LIFE SCIENCE)

INSUMAN (SANOFI AVENTIS)INSUCARE (RANBAXY)

MARKET SHARE

Insulin & its analogs market in 2008 was USD12.25 Bn.

NOVO NORDISK today holds 65% Market Share Globally in Insulin segment.

They are the Market Leaders in Insulin Segment.

Presence in 52 Countries. 5TH LARGEST SELLING BRAND IN INDIA in

May-2009. Annual sales in 2009 was Rs.123.54 Cr. Market Share of 0.34%, Growing at 1.6%

INSULIN Rxn TREND

    Rx TREND % GROWTH

  RANKNOV-

FEB'09JUL-

OCT'08MAR-

JUN'08NOV-

FEB'08 Corrsp. Prev.

Diabeto 7 2437 2594 2672 2546 (4.3) (6.1)

Cardio 35 479 483 527 444 7.9 (0.8)

Cons Phy 48 280 294 318 267 4.9 (4.8)

Nephro 13 1412 1322 1273 1453 (2.8) 6.8

Chest Phy 77 136 123 137 136 0.0 10.6

PREMIXED INSULIN RXN TREND

SPEC. RANK Rx TREND%

GROWTH % SHARE

   NOV-

FEB'09

JUL-OCT'0

8MAR-

JUN'08NOV-

FEB'08CORRS

P. PREV.NOV-FEB'09

JUL-OCT'0

8MAR-

JUN'08NOV-

FEB'08

Diabet 2 1443 1580 1697 1571 (8.1) (8.7) 2.0 2.2 2.4 2.2

Nephro 12 935 850 786 924 1.2 10.0 1.3 1.2 1.2 1.3

Card 51 297 317 318 287 3.5 (6.3) 0.4 0.5 0.5 0.4

Cons Phy 83 174 194 192 159 9.4 (10.3) 0.3 0.3 0.3 0.3

Chest 192 87 78 85 84 3.6 11.5 0.1 0.1 0.1 0.1

BRANDWISE RXN TREND

SPECIALITY RANK BRANDNOV-

FEB'09JUL-

OCT'08MAR-

JUN'08NOV-

FEB'08GROWTH

%

Diabetologost 5 HUMAN MIXTARD 448 476 484 448 0

Nephrologist 10 HUMAN MIXTARD 559 461 417 505 10.7

Cardiologist 39 HUMAN MIXTARD 146 141 141 136 7.3

Cons Physician 80 HUMAN MIXTARD 74 75 70 63 17.5

SPECIALITY RANK BRANDNOV-

FEB'09JUL-

OCT'08MAR-

JUN'08NOV-

FEB'08 GROWTH%

Diabetologost 12 HUMINSULIN 225 242 305 313 -28

Nephrologists 44 HUMINSULIN 223 230 198 272 -17.3

Cardiologist 244 HUMINSULIN 52 53 62 57 -9

Cons Physician 272 HUMINSULIN 38 49 42 39 -2.5

SPECIALITY RANK BRANDNOV-

FEB'09JUL-

OCT'08MAR-

JUN'08NOV-

FEB'08 GROWTH%

Diabetologost 42 WOSULIN 136 150 138 88 54.5

Diabetologost 116 INSUGEN 83 87 98 101 -18

Diabetologost 356 INSUCARE 40 45 43 31 29

CURRENT STRATERGY

QUALITY of Insulin. Focusing on the Fetures of Pens. Patient Services. Free Demo to the patients at their door

step. Free Pens to needy Patients. Complete Range of Insulins available Availability:- Freely Available

WHY DRS PREFER HUMAN MIXTARD ?

Brand Image. Availability. Presence in 52 countries, so widely accepted

by all the Drs world wide. Provides News articles and other Diabetes

related news to the Drs. Other New molecule’s CMEs.

THANK YOU

QUESTIONS?